Live Chat

News

Single cell RNA-sequencing to offer miscarriage hope19th July 2017

A new technique – single cell RNA-sequencing – may offer answers and hope to the 200,000 mothers and partners affected by pregnancy loss in the UK every year. In partnership with Tommy’s National Centre for Miscarriage Research, scientists at the University of Warwick are currently running preliminary studies using the technique.

read more

Single cell RNA-sequencing to offer miscarriage hope
Dolomite Bio’s μEncapsulator System simplifies T-cell profiling25th April 2017

The μEncapsulator System from Dolomite Bio is a complete solution for high throughput encapsulation of individual cells into picoliter droplets. Ideal for profiling natively-paired T-cell receptors (TCRs), this compact, flexible and modular system can process up to 300,000 cells in 15 minutes.

read more

Dolomite Bio’s μEncapsulator System simplifies T-cell profiling
Single cell technology company Dolomite Bio celebrates a successful first year30th March 2017

Dolomite Bio, a brand of Blacktrace Holdings Limited, celebrated the first anniversary of its launch on March 1st, marking the end of a fruitful year in business. This biology-focused brand, a spin out from sister company Dolomite Microfluidics, is dedicated to the development of innovative products for high throughput single cell encapsulation.

read more

Single cell technology company Dolomite Bio celebrates a successful first year
Dolomite Bio launches Injection Valve and Sample Loop for scRNA-Seq11th January 2017

Dolomite Bio has launched a new Injection Valve and Sample Loop for single cell RNA sequencing workflows. This option enables straightforward, gentle introduction of evenly distributed mRNA capture beads into the company’s RNA-Seq System for individual encapsulation of cells.

read more

Dolomite Bio launches Injection Valve and Sample Loop for scRNA-Seq
Dolomite Bio’s Single Cell RNA-Seq System accelerating cancer research9th December 2016

Researchers at The Institute of Cancer Research (ICR), London, are taking advantage of the single cell encapsulation capabilities of Dolomite Bio’s Single Cell RNA-Seq System to investigate resistance mechanisms in prostate cancer. Karolina Nowakowska, a PhD student at The Institute of Cancer Research, explained: “Our team is focused on studying treatment resistance in prostate cancer patients, looking at the biochemical mechanisms responsible.

read more

Dolomite Bio’s Single Cell RNA-Seq System accelerating cancer research